Financial News
Articles published by Xencor, Inc.
![](https://mms.businesswire.com/media/20221110005410/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20221107006010/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Reports Third Quarter 2022 Financial Results
November 07, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20221107006052/en/1222964/5/Xencor_logo_BW.jpg)
Xencor’s IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study
November 07, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20221103005406/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20221031005699/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022
October 31, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20221005005321/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting
October 05, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220908006065/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Appoints Nancy Valente, M.D., to Board of Directors
September 09, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220803005880/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Reports Second Quarter 2022 Financial Results
August 03, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220727005918/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022
July 27, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220526005666/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20220505006085/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Reports First Quarter 2022 Financial Results
May 05, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220428006162/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Host First Quarter 2022 Financial Results Webcast and Conference Call on May 5, 2022
April 28, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220408005336/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20220223006054/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220216005946/en/1362339/5/Xencor_logo_BW.jpg)
Xencor to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 23, 2022
February 16, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220202005908/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Present at Upcoming Investor Conferences
February 02, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220111005561/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Highlights 2022 Corporate Priorities and Portfolio Milestones
January 11, 2022
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20220106005869/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211212005053/en/1222964/5/Xencor_logo_BW.jpg)
Xencor Presents Data from Phase 1 Study of Plamotamab in B-cell Non-Hodgkin Lymphomas at the ASH Annual Meeting
December 12, 2021
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20211121005119/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211119005693/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Present at Upcoming Investor Conferences
November 19, 2021
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20211112005406/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211112005393/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211108006038/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211104005700/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211103005698/en/1222964/5/Xencor_logo_BW.jpg)
![](https://mms.businesswire.com/media/20211102006059/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Present at Upcoming Investor Conferences
November 02, 2021
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20211101005748/en/1222964/5/Xencor_logo_BW.jpg)
Xencor to Host Third Quarter 2021 Financial Results Webcast and Conference Call on November 8, 2021
November 01, 2021
From Xencor, Inc.
Via Business Wire
Tickers
XNCR
![](https://mms.businesswire.com/media/20211004005207/en/1222964/5/Xencor_logo_BW.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.